Similar articles

• Prioritizing the marginalized in the COVID-19 vaccine rollout.

  Braganza BB, Capulong HGM, Gopez JMW, Gozum IEA, Galang JRF. Braganza BB, et al. J Public Health (Oxf). 2021 Jun 7;43(2):e368-e369. doi: 10.1093/pubmed/fdab083. J Public Health (Oxf). 2021. PMID: 33730149 Free PMC article.
• Vaccination: Brazil fails Indigenous people again with two-tier scheme.

  Dos Santos Costa AC, Ahmad S, Essar MY. Dos Santos Costa AC, et al. Nature. 2021 May;593(7860):510. doi: 10.1038/d41586-021-01409-w. Nature. 2021. PMID: 34035528 No abstract available.
• No indigenous peoples left behind on the rolling out of COVID-19 vaccines: considerations and predicaments.

  Sarmiento PJD, Serrano JP, Ignacio RP, Cruz AED, De Leon JC. Sarmiento PJD, et al. J Public Health (Oxf). 2021 Jun 7;43(2):e321-e322. doi: 10.1093/pubmed/fdab032. J Public Health (Oxf). 2021. PMID: 33611595 Free PMC article.
• COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.

  Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC. Meo SA, et al. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877. Eur Rev Med Pharmacol Sci. 2021. PMID: 33629336 Review.
• Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.

  Lambert PH, Ambrosino DM, Andersen SR, Baric RS, Black SB, Chen RT, Dekker CL, Didierlaurent AM, Graham BS, Martin SD, Molrine DC, Perlman S, Picard-Fraser PA, Pollard AJ, Qin C, Subbarao K, Cramer JP. Lambert PH, et al. Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25. Vaccine. 2020. PMID: 32507409 Free PMC article.